Mastoiditis primary prevention: Difference between revisions

Jump to navigation Jump to search
Line 21: Line 21:
* [[Breastfeeding]] infants until at least 6 months of age.<sup>[[Otitis media prevention#cite note-pmid19581824-3|[3]]]</sup>
* [[Breastfeeding]] infants until at least 6 months of age.<sup>[[Otitis media prevention#cite note-pmid19581824-3|[3]]]</sup>
** This is correlated with higher levels of [[antibodies]] to acute otitis media cause nontypeable ''[[Haemophilus influenzae]]'', as well as pathogenic outer membrane [[protein]] P6.
** This is correlated with higher levels of [[antibodies]] to acute otitis media cause nontypeable ''[[Haemophilus influenzae]]'', as well as pathogenic outer membrane [[protein]] P6.
Administering a [[prophylactic]] antibiotic regimen for children at risk for developing recurrent otitis media:
Administering a [[prophylactic]] antibiotic regimen for children at risk for developing recurrent otitis media (such as immunosuppressed children, genetically susceptible):
* Preferred regimen (1): [[Amoxicillin]] 20 mg/kg po once daily.<sup>[[Otitis media prevention#cite note-pmid17054203-4|[4]]]</sup>
* Preferred regimen (1): [[Amoxicillin]] 20 mg/kg po once daily.<sup>[[Otitis media prevention#cite note-pmid17054203-4|[4]]]</sup>
* Preferred regimen (2): [[Sulfisoxazole]] 50 mg/kg po at bedtime.<sup>[[Otitis media prevention#cite note-pmid17054203-4|[4]]]</sup>
* Preferred regimen (2): [[Sulfisoxazole]] 50 mg/kg po at bedtime.<sup>[[Otitis media prevention#cite note-pmid17054203-4|[4]]]</sup>

Revision as of 16:38, 5 July 2017

Mastoiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mastoiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Preventing mastoiditis primarily involves preventing developing otitis media and nasopharyngitis. This is achieved by the pneumococcal and influenza vaccines, frequently washing hands, and avoiding fluid transmission and respiratory droplets from nasopharyngitis patients. Preventing exposure to air pollution as potential middle ear irritants, such as secondhand smoke, contributes to preventing otitis media. For infants, preventative measures include avoiding pacifiers, avoiding daycare enrollment, and breastfeeding until at least 6 months of age. A prophylactic regimen of antibiotics can prevent otitis media in at-risk infants and children.

Primary Prevention

Preventative measures for mastoiditis involve preventing the development of otitis media and nasopharyngitis from infectious pathogens:

  • Avoiding first or secondhand smoke or other air pollutants with potential for middle ear irritation.[2]
  • Avoiding use of pacifiers in infants.
  • Avoiding enrollment in daycares.
  • Breastfeeding infants until at least 6 months of age.[3]

Administering a prophylactic antibiotic regimen for children at risk for developing recurrent otitis media (such as immunosuppressed children, genetically susceptible):

References

Template:WH Template:WS